Dr. Rajeev Mehta, MD
Pulmonology (Pulmonary Disease Physician)
2401 W University Ave
Muncie, IN 47303
Who else practices at this address →
Delaware County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 469
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
IN license 01060210A -
Critical Care Medicine (Internal Medicine) Physician
IN license 01060210A -
Internal Medicine Physician
IN license 01060210A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Indiana University Health Indianapolis, IN
- Indiana University Health Ball Memorial Hospital Muncie, IN
- Lutheran Hospital of Indiana Fort Wayne, IN
- Indiana University Health Jay, Inc. Portland, IN
Medical groups
- Iu Health Medical Group LLC (4,462 clinicians)
- Central Indiana-Amg Specialty Hospital, LLC (9 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 469
- Services billed
- 2,479
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 855 | 151 |
| Established patient office or other outpatient visit, 30-39 minutes | 349 | 195 |
| Test to determine lung volumes using gas dilution or washout | 276 | 274 |
| Test to examine how well the lungs exchange gases | 273 | 271 |
| Test to measure expiratory airflow and volume | 254 | 251 |
| Established patient office or other outpatient visit, 20-29 minutes | 252 | 178 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 227 | 66 |
| Critical care, first 30-74 minutes | 84 | 34 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 82 | 36 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 62 | 60 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Montelukast Sodium Other prescribers in Muncie, IN | 771 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Muncie, IN | 600 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Muncie, IN | 343 |
| Prednisone Other prescribers in Muncie, IN | 269 |
| Theophylline Er (theophylline anhydrous) Other prescribers in Muncie, IN | 269 |
| Spiriva Respimat (tiotropium bromide) Other prescribers in Muncie, IN | 156 |
| Symbicort (budesonide/formoterol fumarate) Other prescribers in Muncie, IN | 136 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Muncie, IN | 125 |
| Pantoprazole Sodium Other prescribers in Muncie, IN | 109 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Muncie, IN | 103 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 60 payments worth $5,771 in total to this clinician.
| Genzyme Corporation | $4,735 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $333 |
| Regeneron Healthcare Solutions, Inc. | $158 |
| Viatris Specialty LLC | $86.25 |
| Amgen Inc. | $79.63 |
| Takeda Pharmaceuticals U.S.A., Inc. | $76.98 |
| GlaxoSmithKline, LLC. | $76.77 |
| Verona Pharma, Inc. | $72.04 |
| Compensation for services other than consulting (speaking, faculty) | $4,424 |
|---|---|
| Food and Beverage | $1,257 |
| Travel and Lodging | $72.10 |
| Education | $17.38 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Mar 20, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $4,424 |
| Genzyme Corporation Mar 20, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Indianapolis, IN | $72.10 |
| Insmed, Inc. Nov 19, 2025 | Education Brinsupri; Brinsupri · Respiratory · in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.